Key result
IV nicardipine reduces systolic aortic pressure by ~38 mm Hg in hypertensive patients.
Why the study?
The hemodynamic effects of nicardipine in patients with angiographically confirmed coronary heart disease were studied to understand its influence on left ventricular hemodynamics and compliance.
Does intravenous nicardipine alter left ventricular hemodynamics in patients with coronary heart disease?
Does intravenous nicardipine alter left ventricular hemodynamics in patients with coronary heart disease?
Intravenous nicardipine effectively reduces aortic pressure and systemic vascular resistance in both normotensive and hypertensive patients with coronary heart disease.
Answers are grounded in this paper and cite their sources.
May support IV nicardipine for acute aortic pressure reduction; hypothesis-generating and requires randomized confirmation before practice change.
The hemodynamic effects of nicardipine were studied in 10 normotensive patients (nine men, one woman; age 43-70 years, mean 56 years) and five patients with mild to moderate hypertension (four men, one woman; age 46-72 years, mean 62.8 years); in all patients coronary heart disease was confirmed by angiography. Hemodynamic parameters were determined before and after intravenous administration of nicardipine in cumulative doses of 2.5, 7.5, and 12.5 mg for 10 min each. Nicardipine significantly reduced systolic aortic pressure, diastolic aortic pressure, and mean aortic pressure in normotensive patients [139 +/- 8.7 vs. 114 +/- 9.2 mm Hg (p < 0.001), 73 +/- 9.1 vs. 56 +/- 7.9 mm Hg (p < 0.001), 97 +/- 7.8 vs. 7.8 +/- 7.9 mm Hg (p < 0.001), respectively] and in hypertensive patients [166 +/- 7.4 vs. 128 +/- 8.6 mm Hg (p < 0.001), 83 +/- 9.4 vs. 56 +/- 10.9 mm Hg (p < 0.001), 110 +/- 15.5 vs. 78 +/- 12.0 mm Hg (p < 0.001), respectively]. Systemic vascular resistance was decreased significantly in hypertensive patients [1,363 +/- 188 vs. 707 +/- 137.7 dyn sec cm-5 (p < 0.001)] and in normotensive patients [1,110 +/- 225.3 vs. 682 +/- 92.4 dyn sec cm-5 (p < 0.001)]. Heart rate increased from 68 +/- 6.8 to 83 +/- 11.4 beats/min (p < 0.001) in normotensive patients but the increase from 72 +/- 14.7 to 80 +/- 14.2 beats/min in hypertensive patients was not significant. Mean pulmonary artery pressure did not change significantly in hypertensive patients and increased slightly in normotensive patients.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Engberding et al. (1990) studied Coronary heart disease (n=15). Nicardipine vs. Baseline (before administration) was evaluated on Systolic aortic pressure in normotensive patients (mm Hg) (p=<0.001). Intravenous nicardipine reduced systolic aortic pressure from 139 to 114 mm Hg in normotensive patients and from 166 to 128 mm Hg in hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: